selonabant



selonabant

N H O N O Cl F F F

SMILES CC(C)(C)NC(=O)N1CC(O[C@H](c2ccc(Cl)cc2)c2ccccc2C(F)(F)F)C1
InChIKey BNLYOVHLLDBOFZ-LJQANCHMSA-N

Chemical Properties

Hydrogen bond acceptors 2
Hydrogen bond donors 1
Rotatable bonds 4
Molecular weight (Da) 440.1


No bioactivity data available.

selonabant

N H O N O Cl F F F

Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV


Compound is not listed as a drug.